title: Blood screening for west nile virus: the cost-effectiveness of a real-time, trigger-based strategy.
abstract: Previous studies have demonstrated that universal blood screening for West Nile virus is not cost-effective. A newly proposed, real-time, trigger-based screening strategy was analyzed and was also shown to be not cost-effective. These results were highly sensitive to pricing of screening assays.
authors.affiliation: Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA. ck2187@columbia.edu
authors.forename: Caroline T
authors.initials: CT
authors.lastname: Korves
authors.forename: Sue J
authors.initials: SJ
authors.lastname: Goldie
authors.forename: Megan B
authors.initials: MB
authors.lastname: Murray
mesh_terms: D003362:Cost-Benefit Analysis; D006801:Humans; D008403:Mass Screening / Q000191:economics*; D014901:West Nile Fever / Q000175:diagnosis*; D014902:West Nile virus / Q000302:isolation & purification*